NEW YORK – Stella Diagnostics on Tuesday announced a collaborative research agreement with the University of Kansas Medical Center to evaluate the clinical use of the company's proteomics panel for patients with Barrett's esophagus.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.